CRO Services (Phase 1-3) Partners
Clinical Trials are required for drug therapies to receive regulatory approval.
A Phase 1 trial is the first to involve human subjects, and their objective is to determine the highest dose of a treatment that can be safely administered to patients. A Phase 2 trial is conducted on a small number of patients to determine if the drug is effective. If the Phase 1 and Phase 2 trials are successful, a larger Phase 3 trial is conducted to gather data to present to the FDA. In a Phase 3 trial a drug is often tested against a placebo or the current standard of care. Clinical trials are expensive and time consuming, and they require expertise in many areas. Sponsors need to perform study startup (which includes site selection and patient recruitment), manage and oversee the trial, and collect and analyze trial data. All of these operations can be performed by a CRO.
How can we help?
Looking for help with your Phase 1-3 project? If you're searching for information or a supplier, let Clinical Leader lend you a hand.
Altasciences
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.
Avance Clinical
The full-service Contract Research Organization (CRO) with operations in Australia, New Zealand, Asia, North America, and Europe, delivering high quality clinical research services to biotech companies for more than three decades. Avance Clinical specializes in world-class operations, providing biotechs with strategic guidance from their pre-clinical development to Phase I early phase with our experienced ClinicReady team through to Phase II to III late-phase studies, supported by our proven GlobalReady team.
Biorasi
Biorasi is the Go-To CRO for global clinical trials! For over 20 years, we have been trusted by small to midsized biopharma companies to provide customized solutions for today's clinical research challenges. Biorasi optimizes clinical studies for multiple therapeutic areas, reaching successful results through reliable, flexible, and accessible solutions provided by our #OneTeam of industry experts.
Capabilities
Have questions about selecting the right Phase 1-3 service provider?
The Clinical Leader team can help. We'll match your needs with the right companies.
Contact us via email for assistance.
Catalyst Flex
Catalyst Flex, a functional service provider (FSP) solution of Catalyst Clinical Research, is a multi-therapeutic niche contract research organization (CRO)with flexible, fit-for-purpose offerings in global resourcing, functional services, and hybrid models for partners and clients in clinical operations, biometrics, medical writing, and safety services. We supply people, process, and technology solutions designed to meet each client’s unique functional needs.
Capabilities
Catalyst Oncology
Catalyst Oncology is a full-service, specialty contract research organization (CRO) built to serve the global biotech industry. We provide customers with teams experienced across all functions, knowledgeable in complex drug classes and study designs, and with data-centric methodologies that help bring next-generation therapies to cancer patients.
Capabilities
CHDR
The Centre for Human Drug Research (CHDR) is an independent, full-service contract research organization (CRO) that specializes in cutting-edge, early phase clinical drug research in both healthy volunteers and small patient cohorts, across a wide range of therapeutic areas.
Dash Bio
Dash Bio is a CRO on a mission to accelerate the process by which drugs are developed. Traditional bioanalysis is slow, manual, and error-prone. Dash changes the equation as the only tech-first bioanalysis partner, putting both speed and quality at the forefront. Processing every sample on an automated platform, they eliminate variability and delays, delivering high quality, GLP-compliant results for preclinical and clinical studies in days, not months.
Capabilities
Ergomed Clinical Research
Ergomed is a global leader in delivering specialized services in oncology, rare disease, and complex trials to the pharmaceutical and biotech sectors. Our comprehensive support covers the entire clinical trial process, from early phase to post-approval, offering full-service, industry-leading clinical trial management solutions as a trusted partner.
Capabilities
inSeption Group
inSeption Group delivers full-service outsourcing, functional service provider solutions, and strategic consulting, with deep expertise in oncology, hematology, neurodegenerative disorders, rare diseases, and cell and gene therapy. By integrating dedicated industry experts who treat your assets with the same care and commitment as you do, we ensure exceptional execution, seamless continuity, and results that truly stand apart.
Capabilities
IQVIA Biotech
IQVIA Biotech delivers flexible clinical development solutions designed to help biotech and emerging biopharma companies get treatments to patients. When you partner with our clinical team, you gain expertise from two decades of running clinical trials exclusively for biotech companies. We understand the unique challenges, hurdles, and opportunities you face. From strategy and trial design to execution, we draw on this experience to put together the right solution for you.
Capabilities
Novotech
Novotech leverages its therapeutic and regulatory expertise, client-centric service model, local market insights, and advanced analytical tools to expedite patient recruitment, enhance trial efficiencies, and bring life-changing therapies to market faster.
Capabilities
palleos healthcare
palleos healthcare is a central European full-service Clinical Research Organization (CRO) focused on product development including pre-clinical consulting and clinical services for small to large scale trials. More than 10,000 patients in 300 sites have been treated throughout various indications.
Precision for Medicine
Precision for Medicine is an industry-leading global precision medicine clinical research organization and a leader in complex clinical development. Our clients benefit from advanced technologies and new approaches that compress timelines, gain efficiencies, and increase the probability of approval. Under one global roof, Precision has integrated sophisticated biomarker capabilities and laboratory expertise, worldwide CRO services, data intelligence solutions, and more.
Capabilities
Quotient Sciences
Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway for small molecule & peptide drug programs. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients.
Capabilities
SGS North America, Inc.
Specialized bioanalytical testing services to support discovery, pre-clinical and Phase 1 - 3 clinical trials. Backed by 30 years of global pharmaceutical testing expertise, SGS provides a complete range of bioanalytical solutions, including Method development, validation and transfer; PK and PD Bioanalysis, ELISA and multiplex assays, bioassays, Immunogenicity testing, and more.
Southern Star Research
Southern Star Research is a full-service CRO dedicated to navigating the complexities of bringing new medical products to market. With a legacy of excellence that began 14 years ago in Sydney, we have grown from a small, passionate team into a global network of experts committed to delivering high-quality services in medical writing, clinical monitoring, project management, biostatistics, data management, safety and medical monitoring, and quality assurance.
Capabilities
TFS HealthScience
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. Dedicated to empowering partners and enriching lives, TFS offers flexible solutions that combine global reach with the agility and responsiveness of a mid-sized CRO.
Capabilities
Thermo Fisher Scientific
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services.
Veristat, Inc.
Veristat, the Science-First™ full service CRO and consultancy, enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development onto regulatory approval and post-marketing. With our focus on novel drug development and 30 years of experience in clinical trial planning and execution, we deliver bold approaches that make the impossible possible.
Capabilities